Watson Rebecca’s iShares Biotechnology ETF IBB Stock Holding History

Watson Rebecca’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-313	Closed	-$43K	–	206
2020 Q2	$43K	Buy	+313	New	+$39.9K	0.03%	170

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Watson Rebecca's IBB Position: Q3 2020 in Review

Watson Rebecca sold out of iShares Biotechnology ETF (IBB) in Q3 2020, closing a stake of 313 shares — an estimated $43K sold.

Watson Rebecca first reported a position in IBB in Q2 2020 and held it in 1 quarter. The position peaked at $43K in Q2 2020. 784 funds tracked by Wall St. Rank hold IBB as of Q3 2020.

Watson Rebecca reported no remaining iShares Biotechnology ETF position as of Q3 2020 after selling out during the quarter.
Watson Rebecca sold 313 iShares Biotechnology ETF shares in Q3 2020, an estimated $43K.
Watson Rebecca first reported a position in iShares Biotechnology ETF in Q2 2020 and held it in 1 quarter.
Watson Rebecca's iShares Biotechnology ETF position peaked at $43K in Q2 2020.
784 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2020.

Based on Watson Rebecca's 13F filing for Q3 2020, filed 22 Oct 2020.